Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab and ipilimumab for metastatic uveal melanoma has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2020-12-10